Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERBB2 - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
GEO DataSets Gene Chromosome neighbors Homologene neighbors
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERBB2 - Lapatinib effect on lapatinib-resistant ErbB2-positive cell line: dose response
ERBB2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ERBB2 - True interval breast cancer
ERBB2 - Ras/MEK inhibition effect on IFN-alpha treated cancer cell line: time course
ERBB2 - Epidermal growth factor effect on HER2-overexpressing mammary epithelial MCF10A cells: time course
ERBB2 - Lapatinib-resistant HER2-positive breast tumor cells
ERBB2 - Triple negative breast cancer
ERBB2 - Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
ERBB2 - Ductal carcinoma in situ: mammary gland
ERBB2 - Stromal cells and invasive breast cancer development
ERBB2 - Tumor suppressor PTEN depletion effect on various cell lines
ERBB2 - Basal-like breast cancer tumors
ERBB2 - Estrogen receptor alpha positive breast cancer cells response to hyperactivation of MAPK pathway
ERBB2 - Estrogen effect on estrogen receptor alpha positive breast cancer cell lines
ERBB2 - Gastric cancer
ERBB2 - Breast cancer cell expression profiles (G4100A)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on